Cargando…
Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to imm...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212440/ https://www.ncbi.nlm.nih.gov/pubmed/32425774 http://dx.doi.org/10.3389/fphar.2020.00503 |
_version_ | 1783531621579751424 |
---|---|
author | Pérez-Sánchez, Natalia Doña, Inmaculada Bogas, Gador Salas, María Testera, Almudena Cornejo-García, José A. Torres, María J. |
author_facet | Pérez-Sánchez, Natalia Doña, Inmaculada Bogas, Gador Salas, María Testera, Almudena Cornejo-García, José A. Torres, María J. |
author_sort | Pérez-Sánchez, Natalia |
collection | PubMed |
description | Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to immunological recognition (selective reactions, SRs), being the latter remarkably less studied. SRs include those usually appearing within the first hour after drug intake (single-NSAID-induced urticaria/angioedema or anaphylaxis, SNIUAA), and those usually occurring more than 24 h after (single-NSAID-induced delayed reactions, SNIDR). We have evaluated the largest series of patients with SRs, analyzing the number of episodes and drugs involved, the latency for reaction onset, the clinical entities, among other variables, as well as the value of available diagnostic methods. Globally, pyrazolones and arylpropionics were the most frequent culprits (39.3% and 37.3%, respectively). Pyrazolones were the most frequent triggers in SNIUAA and arylpropionics in SNIDR. Urticaria was the most common clinical entity in SNIUAA (42.4%) followed by anaphylaxis (33.3%); whereas SNIDR induced mostly fixed drug eruption (41.1%) and maculopapular exanthema (32.6%). The percentage of patients diagnosed by clinical history was higher in SNIUAA compared with SNIDR (62.7% versus 35.3%, p = 0.00015), whereas the percentage of those diagnosed by skin tests was higher in SNIDR than in SNIUAA (47.1% versus 22.8%, p = 0.00015). Drug provocation test with the culprit was performed in 67 SNIUAA (14.5%) and in 9 SNIDR (17.6%) patients. Our results may be of interest not only for allergologists but also for other clinicians dealing with these drugs, and can be useful for the correct identification of subjects experiencing DHRs to NSAIDs, and for avoiding mislabeling. Moreover, as NSAIDs are highly consumed worldwide, our results may be of interest for evaluating other populations exposed to these drugs. |
format | Online Article Text |
id | pubmed-7212440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72124402020-05-18 Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved Pérez-Sánchez, Natalia Doña, Inmaculada Bogas, Gador Salas, María Testera, Almudena Cornejo-García, José A. Torres, María J. Front Pharmacol Pharmacology Non-steroidal anti-inflammatory drugs (NSAIDs), the most commonly prescribed and consumed medicines worldwide, are the main triggers of drug hypersensitivity reactions (DHRs). The underlying mechanisms of NSAID-DHRs may be related to COX-1 inhibition (cross-hypersensitivity reactions, CRs) or to immunological recognition (selective reactions, SRs), being the latter remarkably less studied. SRs include those usually appearing within the first hour after drug intake (single-NSAID-induced urticaria/angioedema or anaphylaxis, SNIUAA), and those usually occurring more than 24 h after (single-NSAID-induced delayed reactions, SNIDR). We have evaluated the largest series of patients with SRs, analyzing the number of episodes and drugs involved, the latency for reaction onset, the clinical entities, among other variables, as well as the value of available diagnostic methods. Globally, pyrazolones and arylpropionics were the most frequent culprits (39.3% and 37.3%, respectively). Pyrazolones were the most frequent triggers in SNIUAA and arylpropionics in SNIDR. Urticaria was the most common clinical entity in SNIUAA (42.4%) followed by anaphylaxis (33.3%); whereas SNIDR induced mostly fixed drug eruption (41.1%) and maculopapular exanthema (32.6%). The percentage of patients diagnosed by clinical history was higher in SNIUAA compared with SNIDR (62.7% versus 35.3%, p = 0.00015), whereas the percentage of those diagnosed by skin tests was higher in SNIDR than in SNIUAA (47.1% versus 22.8%, p = 0.00015). Drug provocation test with the culprit was performed in 67 SNIUAA (14.5%) and in 9 SNIDR (17.6%) patients. Our results may be of interest not only for allergologists but also for other clinicians dealing with these drugs, and can be useful for the correct identification of subjects experiencing DHRs to NSAIDs, and for avoiding mislabeling. Moreover, as NSAIDs are highly consumed worldwide, our results may be of interest for evaluating other populations exposed to these drugs. Frontiers Media S.A. 2020-04-21 /pmc/articles/PMC7212440/ /pubmed/32425774 http://dx.doi.org/10.3389/fphar.2020.00503 Text en Copyright © 2020 Pérez-Sánchez, Doña, Bogas, Salas, Testera, Cornejo-García and Torres http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Pérez-Sánchez, Natalia Doña, Inmaculada Bogas, Gador Salas, María Testera, Almudena Cornejo-García, José A. Torres, María J. Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved |
title | Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved |
title_full | Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved |
title_fullStr | Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved |
title_full_unstemmed | Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved |
title_short | Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved |
title_sort | evaluation of subjects experiencing allergic reactions to non-steroidal anti-inflammatory drugs: clinical characteristics and drugs involved |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212440/ https://www.ncbi.nlm.nih.gov/pubmed/32425774 http://dx.doi.org/10.3389/fphar.2020.00503 |
work_keys_str_mv | AT perezsancheznatalia evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved AT donainmaculada evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved AT bogasgador evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved AT salasmaria evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved AT testeraalmudena evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved AT cornejogarciajosea evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved AT torresmariaj evaluationofsubjectsexperiencingallergicreactionstononsteroidalantiinflammatorydrugsclinicalcharacteristicsanddrugsinvolved |